Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Krishnan Mahesh | Director | 8 | $0 | $21.3K | 2023-08-11 |
| Frohlich Tom | Chief Operating Officer | 53 | $0 | $1.71M | 2023-08-11 |
| King Andrew James | Head of Renal Discovery | 66 | $0 | $1.06M | 2023-08-11 |
| Thomas Dolca | Director | 12 | $212.2K | $0 | 2023-08-11 |
| Oxtoby Andrew | Chief Commercial Officer | 4 | $0 | $0 | 2023-08-11 |
| Jerel Davis | Director, 10% Owner | 57 | $0 | $43.14M | 2023-08-11 |
| Azelby Robert | Director | 4 | $0 | $0 | 2023-08-11 |
| Greenman William Mariner | Director | 20 | $0 | $26.9K | 2023-08-11 |
| AKKARAJU SRINIVAS | Director | 15 | $27.49M | $0 | 2023-08-11 |
| GRIFFIN MICHELLE RENEE | Director | 10 | $0 | $0 | 2023-08-11 |
| DOBMEIER ERIC | President, CEO | 66 | $363.8K | $2.21M | 2023-08-11 |
| BJERKHOLT ERIC | Chief Financial Officer | 33 | $0 | $231.7K | 2023-08-11 |
| Haghighat Ross | Director | 6 | $0 | $0 | 2023-05-26 |
| Versant Voyageurs I Parallel, L.P. | 10% Owner | 5 | $0 | $0 | 2022-04-04 |
| Glicklich Alan | Chief Medical Officer | 14 | $0 | $357.5K | 2022-02-11 |
| Versant Venture Capital VII, L.P. | 10% Owner | 6 | $0 | $27.90M | 2022-01-03 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,300 | $26.12 | $347.4K | 0 | SEC↗ |
| AKKARAJU SRINIVAS | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 23,522 | $25.23 | $593.5K | 0 | SEC↗ |
| AKKARAJU SRINIVAS | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 5,948 | $23.19 | $137.9K | 0 | SEC↗ |
| Azelby Robert | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 7,000 | — | $0 | 0 | SEC↗ |
| Azelby Robert | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 28,200 | $18.40 | $518.9K | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 2,435 | — | $0 | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 14,667 | — | $0 | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 21,000 | — | $0 | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 8,400 | — | $0 | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 16,415 | — | $0 | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 144,787 | $26.02 | $3.77M | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 21,501 | $24.86 | $534.5K | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 88,000 | $27.10 | $2.38M | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 84,000 | $14.73 | $1.24M | 0 | SEC↗ |
| Jerel Davis | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 5,948 | $23.19 | $137.9K | 0 | SEC↗ |
| Jerel Davis | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,300 | $26.12 | $347.4K | 0 | SEC↗ |
| Jerel Davis | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 23,522 | $25.23 | $593.5K | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 300,000 | $27.10 | $8.13M | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 353,358 | $39.65 | $14.01M | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 313,555 | $39.58 | $12.41M | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 271,647 | $25.23 | $6.85M | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 178,600 | $24.86 | $4.44M | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 11,300 | — | $0 | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 255,150 | $14.73 | $3.76M | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 30,797 | — | $0 | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 20,248 | — | $0 | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 50,001 | — | $0 | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer deriv | 2023-08-11 | 2023-08-11 | 64,050 | — | $0 | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 100,000 | $27.10 | $2.71M | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 43,847 | $39.58 | $1.74M | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 119,793 | $25.23 | $3.02M | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 60,000 | $24.86 | $1.49M | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 30,000 | $22.41 | $672.3K | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 8,400 | — | $0 | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 84,000 | $14.73 | $1.24M | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,581 | — | $0 | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 6,801 | — | $0 | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 16,667 | — | $0 | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 21,000 | — | $0 | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 23,522 | $25.23 | $593.5K | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 6,000 | $25.00 | $150.0K | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 6,000 | $23.55 | $141.3K | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 4,000 | $7.00 | $28.0K | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,300 | $26.12 | $347.4K | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 2,600 | — | $0 | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 8,000 | — | $0 | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 3,600 | $35.00 | $126.0K | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 5,948 | $23.19 | $137.9K | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 2,600 | — | $0 | 0 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 23,522 | $25.23 | $593.5K | 0 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 5,948 | $23.19 | $137.9K | 0 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,300 | $26.12 | $347.4K | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 16,667 | — | $0 | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 6,802 | — | $0 | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 21,500 | $22.41 | $481.8K | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 104,000 | $14.73 | $1.53M | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 100,000 | $27.10 | $2.71M | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 6,667 | — | $0 | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 26,000 | — | $0 | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 8,400 | — | $0 | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 43,047 | $39.65 | $1.71M | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 73,047 | $39.58 | $2.89M | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 89,545 | $25.23 | $2.26M | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 60,000 | $24.86 | $1.49M | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 10,152 | — | $0 | 0 | SEC↗ |
| Krishnan Mahesh | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 4,401 | — | $0 | 0 | SEC↗ |
| Krishnan Mahesh | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 26,600 | $23.26 | $618.7K | 0 | SEC↗ |
| Oxtoby Andrew | Chief Commercial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 160,000 | $18.18 | $2.91M | 0 | SEC↗ |
| Oxtoby Andrew | Chief Commercial Officer | D To issuer deriv | 2023-08-11 | 2023-08-11 | 40,000 | — | $0 | 0 | SEC↗ |
| Thomas Dolca | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 23,522 | $25.23 | $593.5K | 0 | SEC↗ |
| Thomas Dolca | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 5,948 | $23.19 | $137.9K | 0 | SEC↗ |
| Thomas Dolca | Director | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,300 | $26.12 | $347.4K | 0 | SEC↗ |
| AKKARAJU SRINIVAS | Director | D To issuer | 2023-08-11 | 2023-08-11 | 3,300 | — | $0 | 0 | SEC↗ |
| AKKARAJU SRINIVAS | Director | D To issuer | 2023-08-11 | 2023-08-11 | 5,161,888 | — | $0 | 0 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | D To issuer | 2023-08-11 | 2023-08-11 | 39,371 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | D To issuer | 2023-08-11 | 2023-08-11 | 719,104 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | D To issuer | 2023-08-11 | 2023-08-11 | 447,013 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | D To issuer | 2023-08-11 | 2023-08-11 | 2,105,107 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | D To issuer | 2023-08-11 | 2023-08-11 | 210,996 | — | $0 | 0 | SEC↗ |
| DOBMEIER ERIC | President, CEO | D To issuer | 2023-08-11 | 2023-08-11 | 301,138 | — | $0 | 0 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | D To issuer | 2023-08-11 | 2023-08-11 | 150,777 | — | $0 | 0 | SEC↗ |
| Greenman William Mariner | Director | D To issuer | 2023-08-11 | 2023-08-11 | 23,643 | — | $0 | 0 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | D To issuer | 2023-08-11 | 2023-08-11 | 3,300 | — | $0 | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | D To issuer | 2023-08-11 | 2023-08-11 | 19,157 | — | $0 | 0 | SEC↗ |
| Krishnan Mahesh | Director | D To issuer | 2023-08-11 | 2023-08-11 | 1,275 | — | $0 | 0 | SEC↗ |
| Thomas Dolca | Director | D To issuer | 2023-08-11 | 2023-08-11 | 13,300 | — | $0 | 0 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2023-08-01 | 2023-08-01 | 1,168 | $39.03 | $45.6K | 19,157 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2023-07-29 | 2023-08-01 | 3,333 | — | $0 | 6,667 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2023-07-29 | 2023-08-01 | 3,333 | — | $0 | 20,325 | SEC↗ |
| Greenman William Mariner | Director | S Sale | 2023-05-30 | 2023-05-31 | 1,155 | $23.30 | $26.9K | 23,643 | SEC↗ |
| Thomas Dolca | Director | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| Haghighat Ross | Director | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| AKKARAJU SRINIVAS | Director | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| Greenman William Mariner | Director | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| Thomas Dolca | Director | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 13,300 | SEC↗ |
| Jerel Davis | Director | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 733,770 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Haghighat Ross | Director | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 124,546 | SEC↗ |
| AKKARAJU SRINIVAS | Director | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Greenman William Mariner | Director | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 24,798 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2023-04-24 | 2023-04-26 | 25,000 | — | $0 | 313,555 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2023-04-24 | 2023-04-26 | 25,000 | $0.42 | $10.5K | 326,138 | SEC↗ |
| DOBMEIER ERIC | President, CEO | S Sale | 2023-04-24 | 2023-04-26 | 23,800 | $21.58 | $513.6K | 302,338 | SEC↗ |
| DOBMEIER ERIC | President, CEO | S Sale | 2023-04-24 | 2023-04-26 | 1,200 | $22.26 | $26.7K | 301,138 | SEC↗ |
| Jerel Davis | Director | S Sale | 2023-04-17 | 2023-04-19 | 295,808 | $20.75 | $6.14M | 443,713 | SEC↗ |
| Azelby Robert | Director | A Award deriv | 2023-04-10 | 2023-04-12 | 7,000 | — | $0 | 7,000 | SEC↗ |
| Azelby Robert | Director | A Award deriv | 2023-04-10 | 2023-04-12 | 28,200 | — | $0 | 28,200 | SEC↗ |
| Krishnan Mahesh | Director | S Sale | 2023-04-04 | 2023-04-04 | 924 | $23.01 | $21.3K | 1,275 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2023-04-03 | 2023-04-05 | 2,500 | — | $0 | 43,047 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2023-04-03 | 2023-04-05 | 5,000 | $23.34 | $116.7K | 16,992 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2023-04-03 | 2023-04-05 | 2,500 | $0.35 | $875 | 21,992 | SEC↗ |
| Krishnan Mahesh | Director | M Exercise deriv | 2023-04-01 | 2023-04-04 | 2,199 | — | $0 | 4,401 | SEC↗ |
| Krishnan Mahesh | Director | M Exercise | 2023-04-01 | 2023-04-04 | 2,199 | — | $0 | 2,199 | SEC↗ |
| Jerel Davis | Director | S Sale | 2023-03-01 | 2023-03-03 | 240,000 | $22.75 | $5.46M | 2,105,107 | SEC↗ |
| Jerel Davis | Director | S Sale | 2023-03-01 | 2023-03-03 | 123,249 | $22.75 | $2.80M | 719,104 | SEC↗ |
| Jerel Davis | Director | S Sale | 2023-03-01 | 2023-03-03 | 36,751 | $22.75 | $836.1K | 210,996 | SEC↗ |
| Oxtoby Andrew | Chief Commercial Officer | A Award deriv | 2023-02-28 | 2023-03-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Oxtoby Andrew | Chief Commercial Officer | A Award deriv | 2023-02-28 | 2023-03-02 | 160,000 | — | $0 | 160,000 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2023-02-10 | 2023-02-15 | 6,803 | — | $0 | 6,802 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise deriv | 2023-02-10 | 2023-02-15 | 6,803 | — | $0 | 6,801 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2023-02-10 | 2023-02-15 | 20,248 | — | $0 | 20,248 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise deriv | 2023-02-10 | 2023-02-15 | 2,435 | — | $0 | 2,435 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2023-02-10 | 2023-02-15 | 2,392 | $23.75 | $56.8K | 19,492 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2023-02-10 | 2023-02-15 | 6,803 | — | $0 | 21,884 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2023-02-10 | 2023-02-15 | 3,700 | $23.75 | $87.9K | 150,777 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise | 2023-02-10 | 2023-02-15 | 6,803 | — | $0 | 154,477 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2023-02-10 | 2023-02-15 | 20,248 | — | $0 | 309,235 | SEC↗ |
| DOBMEIER ERIC | President, CEO | S Sale | 2023-02-10 | 2023-02-15 | 8,097 | $23.75 | $192.3K | 301,138 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise | 2023-02-10 | 2023-02-15 | 2,435 | — | $0 | 39,724 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | S Sale | 2023-02-10 | 2023-02-15 | 857 | $23.75 | $20.4K | 38,867 | SEC↗ |
| DOBMEIER ERIC | President, CEO | A Award deriv | 2023-01-31 | 2023-02-01 | 255,150 | — | $0 | 255,150 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2023-01-31 | 2023-02-01 | 24,999 | — | $0 | 50,001 | SEC↗ |
| DOBMEIER ERIC | President, CEO | A Award deriv | 2023-01-31 | 2023-02-01 | 64,050 | — | $0 | 64,050 | SEC↗ |
| King Andrew James | Chief Scientific Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 26,000 | — | $0 | 26,000 | SEC↗ |
| King Andrew James | Chief Scientific Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 104,000 | — | $0 | 104,000 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2023-01-31 | 2023-02-02 | 8,333 | — | $0 | 16,667 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 84,000 | — | $0 | 84,000 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise deriv | 2023-01-31 | 2023-02-02 | 7,333 | — | $0 | 14,667 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 84,000 | — | $0 | 84,000 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise deriv | 2023-01-31 | 2023-02-02 | 8,333 | — | $0 | 16,667 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2023-01-31 | 2023-02-01 | 24,999 | — | $0 | 296,675 | SEC↗ |
| DOBMEIER ERIC | President, CEO | S Sale | 2023-01-31 | 2023-02-01 | 7,688 | $24.68 | $189.7K | 288,987 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2023-01-31 | 2023-02-02 | 3,244 | $24.68 | $80.1K | 15,081 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2023-01-31 | 2023-02-02 | 8,333 | — | $0 | 18,325 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | S Sale | 2023-01-31 | 2023-02-02 | 2,891 | $24.68 | $71.3K | 37,289 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise | 2023-01-31 | 2023-02-02 | 7,333 | — | $0 | 40,180 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2023-01-31 | 2023-02-02 | 4,566 | $24.68 | $112.7K | 147,674 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise | 2023-01-31 | 2023-02-02 | 8,333 | — | $0 | 152,240 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2023-01-30 | 2023-02-01 | 25,000 | — | $0 | 338,555 | SEC↗ |
| DOBMEIER ERIC | President, CEO | S Sale | 2023-01-30 | 2023-02-01 | 25,000 | $24.54 | $613.5K | 271,676 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2023-01-30 | 2023-02-01 | 25,000 | $0.42 | $10.5K | 296,676 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2023-01-03 | 2023-01-04 | 7,500 | — | $0 | 45,547 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2023-01-03 | 2023-01-04 | 10,000 | $25.82 | $258.2K | 9,992 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2023-01-03 | 2023-01-04 | 7,500 | $0.35 | $2.6K | 19,992 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-12-22 | 2022-12-27 | 108,715 | — | $0 | 247,747 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-12-22 | 2022-12-27 | 9,465 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-12-22 | 2022-12-27 | 5,865 | — | $0 | 9,465 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-12-22 | 2022-12-27 | 1,646 | — | $0 | 739,521 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-12-22 | 2022-12-27 | 3,600 | — | $0 | 3,600 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-12-22 | 2022-12-27 | 364,587 | — | $0 | 842,353 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2022-12-14 | 2022-12-15 | 30,000 | — | $0 | 353,358 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2022-12-14 | 2022-12-15 | 30,000 | $0.35 | $10.5K | 271,676 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise deriv | 2022-12-13 | 2022-12-15 | 10,000 | — | $0 | 43,847 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2022-12-13 | 2022-12-15 | 10,000 | $25.00 | $250.0K | 143,907 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise | 2022-12-13 | 2022-12-15 | 10,000 | $0.42 | $4.2K | 153,907 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2022-12-01 | 2022-12-02 | 60,000 | — | $0 | 363,555 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | S Sale | 2022-12-01 | 2022-12-02 | 5,770 | $22.29 | $128.6K | 32,847 | SEC↗ |
| DOBMEIER ERIC | President, CEO | S Sale | 2022-12-01 | 2022-12-02 | 30,000 | $22.31 | $669.3K | 241,676 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2022-12-01 | 2022-12-02 | 60,000 | $0.42 | $25.2K | 271,676 | SEC↗ |
| DOBMEIER ERIC | President, CEO | G Gift | 2022-12-01 | 2022-12-02 | 25,000 | — | $0 | 211,676 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise deriv | 2022-11-30 | 2022-12-02 | 16,414 | — | $0 | 16,415 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise | 2022-11-30 | 2022-12-02 | 16,414 | — | $0 | 38,617 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise deriv | 2022-11-07 | 2022-11-09 | 10,000 | — | $0 | 53,847 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2022-11-07 | 2022-11-09 | 10,000 | $22.16 | $221.6K | 143,907 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise | 2022-11-07 | 2022-11-09 | 10,000 | $0.42 | $4.2K | 153,907 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2022-10-06 | 2022-10-11 | 10,152 | — | $0 | 10,152 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2022-10-06 | 2022-10-11 | 30,796 | — | $0 | 30,797 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise deriv | 2022-10-06 | 2022-10-11 | 13,582 | — | $0 | 13,581 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2022-10-06 | 2022-10-11 | 3,557 | $19.69 | $70.0K | 12,492 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2022-10-06 | 2022-10-11 | 10,152 | — | $0 | 16,049 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2022-10-06 | 2022-10-11 | 30,796 | — | $0 | 236,676 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2022-10-06 | 2022-10-11 | 7,360 | $19.69 | $144.9K | 143,907 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise | 2022-10-06 | 2022-10-11 | 13,582 | — | $0 | 151,267 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 7,570 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 291,670 | — | $0 | 1,206,940 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 2,878 | — | $0 | 2,878 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 86,972 | — | $0 | 356,462 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 4,692 | — | $0 | 7,570 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 1,316 | — | $0 | 735,900 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 567,963 | — | $0 | 2,345,107 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 11,359 | — | $0 | 11,359 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 11,359 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 1,975 | — | $0 | 737,875 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 9,384 | — | $0 | 9,384 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-09-12 | 2022-09-14 | 9,384 | — | $0 | 0 | SEC↗ |
| Thomas Dolca | Director | P Buy | 2022-09-02 | 2022-09-06 | 300 | $21.20 | $6.4K | 10,000 | SEC↗ |
| Thomas Dolca | Director | P Buy | 2022-09-02 | 2022-09-06 | 9,700 | $21.22 | $205.8K | 9,700 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-08-12 | 2022-08-16 | 108,715 | — | $0 | 443,434 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-08-12 | 2022-08-16 | 364,587 | — | $0 | 1,498,610 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-08-12 | 2022-08-16 | 3,600 | — | $0 | 3,600 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-08-12 | 2022-08-16 | 5,866 | — | $0 | 9,466 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-08-12 | 2022-08-16 | 9,466 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director | J Other | 2022-08-12 | 2022-08-16 | 1,646 | — | $0 | 734,584 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2022-08-04 | 2022-08-05 | 5,000 | — | $0 | 53,047 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2022-08-04 | 2022-08-05 | 5,000 | $0.35 | $1.8K | 10,897 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2022-08-04 | 2022-08-05 | 5,000 | $20.00 | $100.0K | 5,897 | SEC↗ |
| King Andrew James | Chief Scientific Officer | A Award deriv | 2022-07-29 | 2022-08-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2022-07-11 | 2022-07-13 | 5,000 | — | $0 | 58,047 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2022-07-11 | 2022-07-13 | 5,000 | $0.35 | $1.8K | 10,897 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2022-07-11 | 2022-07-13 | 5,000 | $18.09 | $90.5K | 5,897 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2022-05-27 | 2022-06-01 | 570,000 | $14.00 | $7.98M | 5,161,888 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Greenman William Mariner | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Greenman William Mariner | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| Thomas Dolca | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Thomas Dolca | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| GRIFFIN MICHELLE RENEE | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Haghighat Ross | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Haghighat Ross | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| Jerel Davis | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| Jerel Davis | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| DOBMEIER ERIC | President, CEO | P Buy | 2022-05-25 | 2022-05-27 | 5,000 | $13.03 | $65.2K | 205,880 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2022-04-11 | 2022-04-13 | 5,000 | — | $0 | 63,047 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2022-04-11 | 2022-04-13 | 5,000 | $0.35 | $1.8K | 10,897 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2022-04-11 | 2022-04-13 | 5,000 | $15.36 | $76.8K | 5,897 | SEC↗ |
| Jerel Davis | Director, 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 2,468 | — | $0 | 732,938 | SEC↗ |
| Jerel Davis | Director, 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 709,953 | — | $0 | 2,913,070 | SEC↗ |
| Jerel Davis | Director, 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 11,726 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director, 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 11,726 | — | $0 | 11,726 | SEC↗ |
| Jerel Davis | Director, 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 14,194 | — | $0 | 0 | SEC↗ |
| Jerel Davis | Director, 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 14,194 | — | $0 | 14,194 | SEC↗ |
| Versant Voyageurs I Parallel, | 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 11,726 | — | $0 | 0 | SEC↗ |
| Versant Voyageurs I Parallel, | 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 709,953 | — | $0 | 2,913,070 | SEC↗ |
| Versant Voyageurs I Parallel, | 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 14,194 | — | $0 | 14,194 | SEC↗ |
| Versant Voyageurs I Parallel, | 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 14,194 | — | $0 | 0 | SEC↗ |
| Versant Voyageurs I Parallel, | 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 11,726 | — | $0 | 11,726 | SEC↗ |
| Krishnan Mahesh | Director | A Award deriv | 2022-04-02 | 2022-04-05 | 6,600 | — | $0 | 6,600 | SEC↗ |
| Krishnan Mahesh | Director | A Award deriv | 2022-04-02 | 2022-04-05 | 26,600 | — | $0 | 26,600 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2022-02-18 | 2022-02-23 | 2,500 | $13.00 | $32.5K | 5,897 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2022-02-11 | 2022-02-14 | 3,735 | $12.74 | $47.6K | 137,685 | SEC↗ |
| Glicklich Alan | Chief Medical Officer | S Sale | 2022-02-11 | 2022-02-14 | 2,391 | $12.74 | $30.5K | 7,891 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2022-02-11 | 2022-02-14 | 2,498 | $12.74 | $31.8K | 8,397 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | S Sale | 2022-02-11 | 2022-02-14 | 895 | $12.74 | $11.4K | 22,203 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2022-02-10 | 2022-02-11 | 2,500 | — | $0 | 68,047 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise deriv | 2022-02-10 | 2022-02-14 | 6,802 | — | $0 | 13,604 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2022-02-10 | 2022-02-14 | 20,247 | — | $0 | 40,496 | SEC↗ |
| Glicklich Alan | Chief Medical Officer | M Exercise deriv | 2022-02-10 | 2022-02-14 | 5,668 | — | $0 | 11,337 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2022-02-10 | 2022-02-14 | 6,801 | — | $0 | 13,605 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise deriv | 2022-02-10 | 2022-02-14 | 2,434 | — | $0 | 4,870 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2022-02-10 | 2022-02-11 | 2,500 | $0.35 | $875 | 6,594 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2022-02-10 | 2022-02-11 | 2,500 | $13.31 | $33.3K | 4,094 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise | 2022-02-10 | 2022-02-14 | 6,801 | — | $0 | 141,420 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2022-02-10 | 2022-02-14 | 20,247 | — | $0 | 200,880 | SEC↗ |
| Glicklich Alan | Chief Medical Officer | M Exercise | 2022-02-10 | 2022-02-14 | 5,668 | — | $0 | 10,282 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2022-02-10 | 2022-02-14 | 6,801 | — | $0 | 10,895 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise | 2022-02-10 | 2022-02-14 | 2,434 | — | $0 | 23,098 | SEC↗ |
| King Andrew James | Chief Scientific Officer | A Award deriv | 2022-01-31 | 2022-02-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| King Andrew James | Chief Scientific Officer | A Award deriv | 2022-01-31 | 2022-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | A Award deriv | 2022-01-31 | 2022-02-02 | 22,000 | — | $0 | 22,000 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | A Award deriv | 2022-01-31 | 2022-02-02 | 88,000 | — | $0 | 88,000 | SEC↗ |
| DOBMEIER ERIC | President, CEO | A Award deriv | 2022-01-31 | 2022-02-02 | 300,000 | — | $0 | 300,000 | SEC↗ |
| DOBMEIER ERIC | President, CEO | A Award deriv | 2022-01-31 | 2022-02-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | A Award deriv | 2022-01-31 | 2022-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | A Award deriv | 2022-01-31 | 2022-02-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Jerel Davis | Director, 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 308,000 | $16.00 | $4.93M | 1,863,197 | SEC↗ |
| Jerel Davis | Director, 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 92,000 | $16.00 | $1.47M | 552,149 | SEC↗ |
| Jerel Davis | Director, 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 600,000 | $16.00 | $9.60M | 3,623,023 | SEC↗ |
| Versant Venture Capital VII, L | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 308,000 | $16.00 | $4.93M | 1,863,197 | SEC↗ |
| Versant Venture Capital VII, L | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 92,000 | $16.00 | $1.47M | 552,149 | SEC↗ |
| Versant Venture Capital VII, L | 10% Owner | S Sale | 2022-01-03 | 2022-01-05 | 600,000 | $16.00 | $9.60M | 3,623,023 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2021-12-23 | 2021-12-27 | 40,000 | — | $0 | 383,358 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise | 2021-12-23 | 2021-12-27 | 40,000 | $0.35 | $14.0K | 180,633 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise deriv | 2021-12-01 | 2021-12-03 | 16,414 | — | $0 | 32,829 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | M Exercise | 2021-12-01 | 2021-12-03 | 16,414 | — | $0 | 26,414 | SEC↗ |
| BJERKHOLT ERIC | Chief Financial Officer | F Tax w/h | 2021-12-01 | 2021-12-03 | 5,750 | $16.02 | $92.1K | 20,664 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2021-11-15 | 2021-11-17 | 1,215,000 | $14.00 | $17.01M | 4,591,888 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2021-11-10 | 2021-11-12 | 6,230 | $15.48 | $96.4K | 134,619 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2021-11-09 | 2021-11-12 | 2,500 | — | $0 | 70,547 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise | 2021-11-09 | 2021-11-12 | 2,500 | $0.35 | $875 | 9,094 | SEC↗ |
| King Andrew James | Chief Scientific Officer | S Sale | 2021-11-09 | 2021-11-12 | 5,000 | $13.53 | $67.7K | 4,094 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2021-11-08 | 2021-11-09 | 13,770 | $15.17 | $208.9K | 140,849 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise deriv | 2021-11-05 | 2021-11-09 | 15,000 | — | $0 | 63,847 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise | 2021-11-05 | 2021-11-09 | 15,000 | $0.42 | $6.3K | 174,619 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2021-11-05 | 2021-11-09 | 5,000 | $14.00 | $70.0K | 154,619 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | S Sale | 2021-11-05 | 2021-11-09 | 15,000 | $14.00 | $210.0K | 159,619 | SEC↗ |
| Greenman William Mariner | Director | M Exercise deriv | 2021-10-21 | 2021-10-22 | 1,663 | — | $0 | 0 | SEC↗ |
| Greenman William Mariner | Director | M Exercise | 2021-10-21 | 2021-10-22 | 1,663 | $2.60 | $4.3K | 21,498 | SEC↗ |
| Glicklich Alan | Chief Medical Officer | M Exercise deriv | 2021-10-06 | 2021-10-08 | 7,103 | — | $0 | 14,208 | SEC↗ |
| King Andrew James | Chief Scientific Officer | M Exercise deriv | 2021-10-06 | 2021-10-08 | 10,151 | — | $0 | 20,304 | SEC↗ |
| DOBMEIER ERIC | President, CEO | M Exercise deriv | 2021-10-06 | 2021-10-08 | 30,796 | — | $0 | 61,593 | SEC↗ |
| Frohlich Tom | Chief Operating Officer | M Exercise deriv | 2021-10-06 | 2021-10-08 | 13,580 | — | $0 | 27,163 | SEC↗ |
| Glicklich Alan | Chief Medical Officer | M Exercise | 2021-10-06 | 2021-10-08 | 7,103 | — | $0 | 7,103 | SEC↗ |
| Glicklich Alan | Chief Medical Officer | F Tax w/h | 2021-10-06 | 2021-10-08 | 2,489 | $12.37 | $30.8K | 4,614 | SEC↗ |
| King Andrew James | Chief Scientific Officer | F Tax w/h | 2021-10-06 | 2021-10-08 | 3,557 | $12.37 | $44.0K | 6,594 | SEC↗ |